Genetically modified mice with tamoxifen-induced inhibition of Atg5 in the proximal tubules demonstrated renal failure, the atrophy of kidney tissue, mitochondrial dysfunction, and an increase in oxidative stress products in the kidney [47]. The gene discussed is ATG5; the disease is acute kidney injury.